Ontology highlight
ABSTRACT: Background
To date, the economic burden and patient-reported outcomes associated with carcinoid syndrome (CS) in patients with neuroendocrine tumor (NET) remain largely unknown.Objectives
The objective of this study was to perform a systematic review of economic and quality-of-life (QOL) studies related to the treatment of CS.Methods
Articles included in the review were extracted from PubMed, Embase, and the Cochrane Library. Studies had to be in English and published between 1 January 2000 and 2 July 2020. Other study eligibility criteria included patients with NET with CS receiving treatment for CS, study outcomes of cost or QOL, and clinical trials or population-based studies using claims or other secondary databases. The interventions included somatostatin analo
SUBMITTER: Pan IW
PROVIDER: S-EPMC9109155 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature